Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial

Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page has removed the 'Last Update Posted (Estimated)' section and replaced it with a more definitive 'Last Update Posted' section.
    Difference
    0.0%
    Check dated 2025-05-20T00:22:00.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The webpage has updated several site locations and contact information, including new research centers and their respective addresses and phone numbers, while removing outdated entries. Notably, the dates for some events have also been revised.
    Difference
    7%
    Check dated 2025-05-11T20:05:22.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-27T12:45:25.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The webpage has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial related to schizophrenia, while adding a new identifier and a revision number.
    Difference
    19%
    Check dated 2025-04-20T07:07:04.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The study has increased its locations from 171 to 173, with several updates to site contacts and details, including new names and locations in the United States and abroad.
    Difference
    8%
    Check dated 2025-04-05T20:23:18.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page has been updated to reflect an increase in study locations from 170 to 171, with several specific location details and contact information being modified. Notably, the contact person for Site 144 has changed from Evagelos Coskinas to Gerald Maguire.
    Difference
    4%
    Check dated 2025-03-06T03:52:05.000Z thumbnail image

Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.